Pfizer
Pfizer suffers Alzheimer’s setback
March 4, 2010Research and Development Alzheimer's, Medivation, Pfizer
Pfizer has suffered a big setback with the oral Alzheimer’s disease treatment it is developing with biotech outfit Medivation. Investigational …
Pfizer’s Kristin Peck gains business development role
March 1, 2010Sales and Marketing Pfizer, appointment, sales and marketing
Kristin Peck has been appointed senior vice president, worldwide business development, strategy and innovation at Pfizer. She succeeds William Ringo …
77 million Europeans fuelling counterfeits market
February 19, 2010Sales and Marketing Europe, Pfizer, counterfeits
A new survey commissioned by Pfizer shows that Europeans are fuelling a counterfeit medicines market worth €10.5 billion.The findings are …
Pfizer launches e-payment scheme for emerging markets
February 8, 2010Sales and Marketing Pfizer, discount, em, emerging markets
Pfizer is reaching further into emerging markets with the launch of an e-payment scheme that offers patients deep discounts on …
Pfizer to personalise brain tumour vaccine
February 8, 2010Research and Development Pfizer, Qiagen, brain tumour, gliobastoma, vaccines
Pfizer is working with Dutch company Qiagen to develop a companion diagnostic kit for its immunotherapy vaccine for gliobastoma multiforme. …
Pharma manufacturing news in brief
February 8, 2010Manufacturing and Production, Medical Communications Angel Biotech, Catalent, Enzon, Genzyme, Gorbec Pharmaceuticals Services, Peakdale Molecular, Pfizer, Sigma-Tau, Synco Bio Partners
Our round-up of news in the pharmaceutical manufacturing arena covers developments at Genzyme, Enzon/Sigma-Tau, Catalent, Synco Bio Partners, Angel Biotech, …
Wyeth acquisition yet to shake Pfizer’s Lipitor dependence
February 4, 2010Sales and Marketing 2009 financials, Lipitor, Pfizer
Pfizer’s profits rose by 7% last year on the back of a 4% increase in revenue driven by cholesterol treatment …
Pfizer abandons 100 projects in R&D streamlining
January 28, 2010Research and Development Pfizer
Pfizer has released details of its new consolidated pipeline following its merger with Wyeth, announcing new priority research areas, and …
Awards recognise top pharma manufacturing projects
January 19, 2010Manufacturing and Production Biogen, Genentech, Mannkind, Pfizer
The winners of the 2010 Facility of the Year Awards have been made public, with Pfizer grabbing two out of …
Pfizer signs ‘personalised’ cancer collaboration
January 15, 2010Research and Development Cancer, Debiopharm, Pfizer, melanoma, skin cancer, tremelimumab
Pfizer is to co-develop its monoclonal antibody treatment for advanced melanoma with Swiss company Debiopharm. The companies will conduct phase …
Manufacturing news in brief
January 12, 2010Manufacturing and Production ACell, Cel-Sci, Dr Reddy's Laboratories, Genzyme, Mannkind, Pfizer, Transgene Biotek, Viva Pharmaceutical
This week’s rundown of manufacturing news includes a delay for Mannkind’s inhaled insulin product Afrezza, more job losses at Pfizer …
Pharma mergers and acquisitions in 2009
December 22, 2009Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review
This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
Pfizer gives notice of staff cuts at former Wyeth plant
December 14, 2009Manufacturing and Production Pfizer, US
Pfizer says it will cut around 200 staff at its Pearl River manufacturing facility in New York, US, according to …
BMS and Pfizer will file apixaban in Europe next year
December 8, 2009Sales and Marketing BMS, Pfiizer, Pfizer, VTE, apixaban
Bristol-Myers Squibb and Pfizer are to submit their new anti-clotting drug for European approval in the first half of next …
Digital Pharma: Pfizer launches European YouTube channel
December 2, 2009Medical Communications, Sales and Marketing Pfizer, digi, digital pharma, youtube
Pfizer has set up a YouTube channel to promote its European operations by showcasing some of its people.In one sequence …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
